维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="Yarboro"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	ICF core sets:how to specify impairment and function in systemic Lupus erythematosus显示文摘	Aringer M Stamm TA Pisetsky DS Yarboro CH Cieza A Smolen JS	2006	Lupus2006，15，：	1
2	Deficient CD4+ CD25high T regulatory cell function in patients with active systemic lupus erythe- matosus 显示文摘	Valencia X Yarboro C Illei G	2007	J Immunol2007，178，4：	1
3	Impact of anti-interleukin-6 re- ceptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus 显示文摘	Shirota Y Yarboro C Fischer R	2013	Ann Rheum Dis2013，72，1：	1
4	Tocil- izumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study 显示文摘	ILLEI G G SHIROTA Y YARBORO C H	2010	Arthritis Rheum2010，62，2：	1
5	Deficient CD4+CD25higb T regulatory cell function in patients with active systemic lupus erythematosus显示文摘	Valencia X Yarboro C Illei G		0，，04：	1
6	Failureof low- dose intravenous immunoglobulin therapy to suppressdisease activity in patients with treatment- refractory rheuma-toid arthritis显示文摘	KANIK K S YARBORO C H NAPARSTEK Y	1996	Arthritis Rheum1996，39，10：	1
7	Distinct patterns of cy- tokine secretion characterize new onset synovitis verus chronic rheumatoid arthritis 显示文摘	Kanik KS Hagiwara E Yarboro CH	1998	J Rheumatol1998，25，1：	1
8	Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis显示文摘	Kanik KS Hagiwara E Yarboro CH	1998	J Rheumatol1998，25，1：	1
9	Tocilizumab in systemic lupus erythematosus : data on safety, preliminary efficacy, and impact on cir- culating plasma cells from an open-label phase 1 dosage-escalation study显示文摘	Illei GG Shirota Y Yarboro CH	2010	Arthritis and Rheumatism2010，62，2：	1
10	Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus显示文摘	Shirota Y Yarboro C Fischer R	2013	Ann Rheum Dis2013，72，：	1
11	Impact of anti-interleukin-6 receptor blockade on circulating T and B cellsubsets in patients with systemic lupus erythematosus显示文摘	Shirota Y Yarboro C Fischer R		0，，01：	1
12	Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus显示文摘	Valencia X Yarboro C Illei G	2007	J Immunol2007，178，4：	1
13	Deficient CD4+CD25 high T regulatory cell function in patients with active systemic lupus erythematosus显示文摘	Vaencia X Yarboro C lllei G el al	2007	J Immunol2007，178，4：	1
14	Deficient CD4 + CD25highT regu- latory cell function in patients with active systemic lupus erythematosus 显示文摘	Valencia X Yarboro C nlei G	2007	J Immunol2007，178，4：	1
15	Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis显示文摘	KANIK K S HAGIWARA E YARBORO C H	1998	J Rheumatol1998，25，1：	1
16	Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis显示文摘	Kanik KS Hagiwara E Yarboro CH	1998	J Rheumatol1998，25，1：	1
17	Anti- N- methyl- D- aspartate receptor antibodies,cognitive dysfunction,and depression in systemic lupus erythematosus显示文摘	LAPTEVA L NOWAK M YARBORO CH		0，，08：	1
18	Deficient CD4+CD25high T regula-tory cell function in patients with active systemic lupuserythematosus显示文摘	Valencia X Yarboro C	2007	J Immunol2007，178，4：	1
19	Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus显示文摘	Shirota Y Yarboro C Fischer R	2012	Ann Rheum Dis2012，8，2：	1
20	Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis显示文摘	KANIK K S Hagiwara E YARBORO C H	1998	Rheumatol1998，25，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示